Corrigendum: The Application of Regulatory Cascades in Streptomyces: Yield Enhancement and Metabolite Mining

Abstract

A Corrigendum on The Application of Regulatory Cascades in Streptomyces: Yield Enhancement and Metabolite Mining by Xia, H., Li, X., Li, Z., Zhan, X., Mao, X., and Li, Y. (2020). Front. Microbiol. 11:406. doi: 10.3389/fmicb.2020.00406 In the original article, there was some errors. A portion of this text was reproduced from another article, this has now been rephrased and appropriately attributed. A correction has been made to The Regulatory Cascades of Antibiotic Production in Streptomyces, paragraph 5: The fourth level is the feedback regulation which is brought by antibiotic and/or intermediates to coordinate antibiotic production and transport. Evidence has shown that antibiotic functions as signals to regulate the production of antibiotic besides as feedback substances for the enzymatic reactions. Antibiotic, as ligand for proper regulator, affects the final production in Streptomyces. The expression of antibiotic biosynthetic genes was modulated by the RedZ and undecylprodigiosin complex (Wang et al., 2009). The activity of AtrA, which regulates primary and secondary metabolism, is reduced by lidamycin of Streptomyces globisporus and actinorhodin (ACT) of S. coelicolor (Li et al., 2015). The biosynthesis of jadomycin is dynamically modulated by the interaction among jadomycin B, chloramphenicol, JadR1 and JadR2 in Streptomyces venezuelae (Wang et al., 2009; Xu et al., 2010). Daunorubicin (DNR) biosynthesis is regulated by three DNA binding regulatory proteins (DnrI, DnrN, and DnrO). The DNA binding activity of DnrO can be modulated by Rhodomycin D, a glycosylated precursor of DXR (Jiang and Hutchinson, 2006). Simocyclinone and its precursors inhibit the binding activity of SimReg1 to several promoter regions of simocyclinone biosynthesis genes and SimReg1 encoding gene (Horbal et al., 2012). As a GBL receptor-like protein, PapR5, which is the major regulator of pristinamycin biosynthesis, may sense pristinamycin or intermediate(s) of the pathway (Mast et al., 2015). SsaA can activate sansanmycin biosynthesis by binding to five different regions within the sansanmycin BGC. The sansanmycins A and H inhibit DNA-binding activity of SsaA in a concentration-dependent manner (Li et al., 2013). The rifamycin B, the end product of rifamycin biosynthesis, can relieve the repression of RifQ on the transcription of the rifamycin efflux pump (RifP) (Lei et al., 2018). Transporters may affect product maturation. Deletion of nysG and nysH, two ABC transporters encoding genes, resulted in ca. 35% reduction of nystatin production and accumulation of its deoxy precursor in Streptomyces noursei. NysGH complex is prone to export nystatin. Its activity would enhance the last biosynthetic step by relief of the feedback through final product removal (Sletta et al., 2005). ‘LanT,’ the dedicated ABC transporter for both class I and II lantibiotics, plays an important role in production of the final product (Gebhard, 2012). A correction has been made to Enhancing Antibiotic Production by Overexpression of Positive Regulator Genes, paragraph 1: The regulators also can be defined as positive and negative regulators according their effect on the antibiotic production. The positive regulators (activators) can promote the biosynthesis of antibiotics. But the negative ones (repressors) can repress the biosynthesis of antibiotics (Martin and Liras, 2010). Since the positive regulators activate the transcription of antibiotic BGCs, they can be manipulated to enhance the production of antibiotic in Streptomyces. The titer improvement can efficiently and simply be achieved by over-expression of genes encoding activators with proper promoters. As listed in Table 1, overexpression of genes encoding LAL family regulators, such as MilR, NemR, and AveR, has been used to increase production of milbemycin in S. bingchenggensis BC04, nemadectin in S. cyaneogriseus subsp. non-cyanogenus NMWT1 and avermectin in S. avermitilis, respectively (Guo et al., 2010; Zhang et al., 2016; Li et al., 2019). Overexpression of sanG, a CSR activator encoding gene, led to improvement of nikkomycin production (Liu et al., 2005). Tandem copies of otcR (a CSR activator gene), whose expression is driven by the SF14 promoter, can greatly enhance the production of oxytetracycline (OTC) (Yin et al., 2015). There are many examples in similar strategies to improve antibiotic production in Streptomyces. Overexpression of bulZ, fkbR1, wysR, and lnmO led to overproduction of tacrolimus (FK506), ascomycin, wuyiencin, and leinamycin, respectively (Liu et al., 2014; Huang et al., 2016; Song et al., 2017; Ma et al., 2018). A correction has been made to Enhancing Antibiotic Production by Manipulation of Feedback and Transport, Paragraph 1: Genes encoding exporters, which are responsible for the secretion of antibiotic, often situate in their BGCs. Various BGC-linked transporters, belonging to ATP-binding cassette (ABC) superfamily and major facilitator superfamily (MFS) are responsible for secreting antibiotics. Pumping out of toxic end-products can achieve more durable and sustainable productivity. In the section Enhancing Antibiotic Production by Manipulation of Feedback and Transport, Paragraphs 2, 3, and 4 should be replaced with the following text; It has been proved that the expression of BGCs was greatly affected by the secretion of end-products, even without toxicity. ActA (ActII-ORF2) and ActB (ActIIORF3), activate the transcription of BGCs in a feed-forward by transportation of the end-products (Tahlan et al., 2007; Xu et al., 2012). Only one fifth of ACT was produced by the actAB mutant. There are two waves for ACT production. The expression of key act genes is initially induced by an ACT biosynthetic intermediate. The ACT production is fully induced only when the inner ACT is pumped out. Overexpression of AvtAB, an ABC transporter, enhance the production of avermectin B1a with two-folds. But the production level of oligomycin A,...